Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:20:59.969Z.
Calculation as of: 2026-10-06T18:20:59.969Z.
Quote observation: 2026-10-06T18:20:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8c517f571e23d8c9640577b72a0d01a1674ca2fb527f0620093024032568825b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Cogent Biosciences, Inc.
Market Cap
$5.17B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.17B
Free Cash Flow Yield
1.00%
TTM Avg
0.53%
3Y Avg
0.53%
5Y Avg
0.53%
Market Cap
$5.24B
Free Cash Flow Yield
2.15%
TTM Avg
2.27%
3Y Avg
2.17%
5Y Avg
2.45%
Market Cap
$5.27B
Free Cash Flow Yield
N/A
TTM Avg
8.07%
3Y Avg
4.52%
5Y Avg
4.52%
Market Cap
$5.28B
Free Cash Flow Yield
5.67%
TTM Avg
5.52%
3Y Avg
3.51%
5Y Avg
2.87%
Market Cap
$5.07B
Free Cash Flow Yield
N/A
TTM Avg
3.62%
3Y Avg
3.62%
5Y Avg
3.62%
Market Cap
$5.06B
Free Cash Flow Yield
4.02%
TTM Avg
3.85%
3Y Avg
2.74%
5Y Avg
2.55%
Market Cap
$5.03B
Free Cash Flow Yield
4.90%
TTM Avg
5.72%
3Y Avg
3.49%
5Y Avg
3.49%
Market Cap
$5.34B
Free Cash Flow Yield
N/A
TTM Avg
11.26%
3Y Avg
11.26%
5Y Avg
11.26%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.17B | N/A | N/A | N/A | N/A |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.17B | 1.00% | 0.53% | 0.53% | 0.53% |
| Sotera Health Company (SHC)vs › | $5.24B | 2.15% | 2.27% | 2.17% | 2.45% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.27B | N/A | 8.07% | 4.52% | 4.52% |
| Doximity, Inc. (DOCS)vs › | $5.28B | 5.67% | 5.52% | 3.51% | 2.87% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.07B | N/A | 3.62% | 3.62% | 3.62% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 4.02% | 3.85% | 2.74% | 2.55% |
| Waystar Holding Corp. (WAY)vs › | $5.03B | 4.90% | 5.72% | 3.49% | 3.49% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.34B | N/A | 11.26% | 11.26% | 11.26% |
| Erasca, Inc. (ERAS)vs › | $5.00B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
